CARDIOVASCULAR AND RENAL PRIORITY RESEARCH AREA
Through the development of the Kolling Institute Research Strategy, the benefits of connecting the emerging area of cardiovascular research with the well-established area of renal medicine and associated research, were identified. Cardiovascular research has developed at the Kolling in recent years following several high-profile recruits, the Federal Government’s Mission for Cardiovascular Health and NSW Government investment. The institute is in a strong position to capitalise on government investment in this area.
Northern Blood Research Centre
Translational Cardiology Research Lab
Cardiovascular & Hormonal Research Lab
Preventative Cardiology and Heart Failure
Women and Babies Research
Ageing and Pharmacology Lab
Nursing
CARDIOVASCULAR AND RENAL PRIORITY RESEARCH AREA
Cardiovascular Discovery Group
Cardiac Membrane Biology Lab
Cardiac Biology and Heart Failure
Cardiology Clinical Trials Unit
Renal Clinical Trials Unit
Renal Research
USYD Cardiovascular Magnetic Resonance Group
North Shore Vascular Surgery
Endocrinology
Researchers within this priority research area are diverse, spanning bench to bedside, to business research. Scientists within the Kolling are closely linked to well- respected clinical teams within Royal North Shore Hospital. In renal medicine, the Kolling has strong connections to industry, with co-authorships a point of distinction from other Australian institutes of medical research. This priority research area receives strong funding support from the National Health and Medical Research Council, industry partnerships and philanthropy.
The research strategy will see closer ties developed with the University of Sydney’s Charles Perkins Centre, given the synergies with the translational centre and cardiovascular and diabetes research at the Kolling.
10
Made with FlippingBook - professional solution for displaying marketing and sales documents online